Clinical TrialsSearch results
Number of results: 231
Other
- An open-label randomized trial of web-based educational program for diagnostic capability of skin tumor
- skin tumor
- Department of Epidemiology and Healthcare Research, Graduate School of Medicine, Kyoto University
- 2008-12-31
Completed
- DREAM study
- Small cell lung cancer
- Fujimoto Daichi
- 2021-01-15
Not yet recruiting
- Guidelines for Scientific Exercise Therapy for People with Spinal Cord Injury
- spinal cord injury
- Umemoto Yasunori
- 2022-12-23
Other
- Trial for Cerebellar Ataxia Rehabilitation
- Spinocerebellar degeneration
- Brain Research Institute, Niigata University
- 2007-09-12
Other
- A Study of Bemarituzumab Monotherapy and Combination With Other Anti-cancer Therapy in SqNSCLC WithFGFR2b Overexpression (FORTITUDE-201)
- Squamous-Cell Non-Small-Cell Lung Cancer
- Kaneda Hirokazu
- 2022-05-03
Other
- A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervix
- stage 1b2/2 cervical cancer
- Japanese Gynecologic Oncology Group
- 2006-12-21
Other
- A combination of cyclosporine and prednisolone and a combination of methylprednisolone, cyclosporine and prednisolone for steroid-resistant nephrotic syndrome in children: A randomized controlled study
- Steroid-resistant nephrotic syndrome in children
- Japanese Study Group of Kidney Disease in Children
- 2005-08-01
Other
- Treatment for steroid-resistant nephrotic syndrome in children: a combination of cyclosporine and prednisolone in minimal change and a combination of methylprednisolone, cyclosporine and prednisolone in FSGS
- Steroid-resistant nephrotic syndrome in children
- Japanese Study Group of Renal Disease in Children
- 2005-08-01
Other
- Mizoribin for primary nephrotic syndrome in children(JSRDC09)
- Steroid-sensitive nephrotic syndrome
- Japanese Study Group of Renal Disease in Children(JSRDC)
- 2006-04-01
Other
- Prednisolone only and a combination of prednisolone and mizoribine for primary nephrotic syndrome relapsed within six mounths after first onset in children: A randomized controlled trial of efficacy and safety (JSRDC06)
- Steroid-sensitive nephrotic syndrome
- Japanese Study Group of Renal Disease in Children(JSRDC)
- 2006-04-01